Global Perspectives on Hepatocellular Carcinoma
Nov
17
2024
Convention Center: Ballroom 6D
8:00 AM - 9:30 AM
World Class Speakers
Description
This session will focus on global aspects of hepatocellular carcinoma, exploring the epidemiology, different risk factors and treatment approaches for hepatocellular carcinoma in various regions of the world. Leading experts from each region will present on specific aspects of HCC that are important globally and regionally.Journey Maps
Presentations
8:00 AM - 8:15 AM
Nov
17
2024
San Diego, CA
Global Epidemiology and Burden of Hepatocellular Carcinoma
Lewis R Roberts, MBChB, PhD, FAASLD, Presenter
DEI
Liver Cancer
8:15 AM - 8:30 AM
Nov
17
2024
San Diego, CA
Early onset hepatocellular carcinoma in Africans, South Americans, and Alaskan Natives:clues to pathogenesis?
Hailemichael Desalegn, MD, PhD, Presenter
DEI
Liver Cancer
8:30 AM - 8:45 AM
Nov
17
2024
San Diego, CA
Systemic therapy for hepatocellular carcinoma, population-specific outcomes
Federico Piñero, MD, Msc, PhD, Presenter
DEI
Liver Cancer
8:45 AM - 9:00 AM
Nov
17
2024
San Diego, CA
Non-viral hepatitis related hepatocellular carcinoma: A New breed or more of the same?
Grace LH Wong, MD, FRCP, FHKCP, Presenter
DEI
Liver Cancer
Objectives
- Explain the epidemiology and prevalence of hepatocellular carcinoma in different regions of the world
- Describe the impact of risk factors for development of hepatocellular carcinoma from different regions of the world
- Discuss the variations in therapeutic options and treatment implementation for HCC according to resource availability
Chair
Saro Khemichian, MD
University of Southern California-Keck School of Medicine